Armata Pharmaceuticals (ARMP) Other Non-Current Liabilities (2013 - 2019)

Armata Pharmaceuticals (ARMP) has 7 years of Other Non-Current Liabilities data on file, last reported at $1.3 million in Q4 2019.

• For the quarter ending Q4 2019, Other Non-Current Liabilities rose 20.59% year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2019 stood at $1.3 million (up 20.59% YoY), and the FY2019 full-year result was $1.3 million, up 20.59% from the prior year.
• Other Non-Current Liabilities grew to $1.3 million in Q4 2019, from $1.2 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $14.7 million in Q1 2015 to a low of $2000.0 in Q1 2016.
• A 5-year average of $2.4 million and a median of $1.2 million in 2019 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities plunged 99.99% in 2016 and jumped 116350.0% in 2017, its largest moves.
• Tracing ARMP's Other Non-Current Liabilities over 5 years: stood at $1.5 million in 2015, then jumped by 62.98% to $2.4 million in 2016, then plunged by 88.05% to $292000.0 in 2017, then jumped by 282.53% to $1.1 million in 2018, then climbed by 20.59% to $1.3 million in 2019.
• Business Quant data shows ARMP's Other Non-Current Liabilities at $1.3 million in Q4 2019, $1.2 million in Q3 2019, and $1.2 million in Q1 2019.